The Journal
References
1. NeemaAgrawal, P. V. N. Dasaradhi,
AsifMohmmed, PawanMalhotra, Raj K.
Bhatnagar, and Sunil K. Mukherjee, 2003, RNA
Interference: Biology, Mechanism, and
Applications, International Center for Genetic
Engineering and Biotechnology, New Delhi 110
067, India
2. GR Devi, 2006, siRNA-based approaches in
cancer therapy, Comprehensive Cancer
Center, Duke University Medical Center,
Durham, NC, USA
3. Beverly L. Davidsonand Paul B. McCray,
2011, Current prospects for RNA interference-
based therapies, Nature reviews , Genetics
,Volume 12 , Page 328
4. Abhijit Banerjee and NylaDil ,
2 0 1 0 , D e v e l o p m e n t
o f
RNAiImmunotherapeutics& Prognostic
Markers to Treat and Prevent Progression of
Oral Cancers at Early Stage, Oral Biology ,
University of Manitoba
5.Yanamoto et al , 2005 , Silencing of the p53R2
gene by RNA interference inhibits growth and
enhances 5-fluorouracil sensitivity of oral
cancer cells, Cancer Letters, 223(1), pp.67-76;
2005
38
6. Ying-Ling Chen , 2009, RNAi screening for
novel biomarkers from human oral cancer,
Department of Medical Laboratory Science and
Biotechnology and School of BiologicalScience
and Technology, China Medical University,
Taichung, Taiwan
7. Liang X et al , 2008, RNAi-mediated
downregulation of urokinase plasminogen
activator receptor inhibits proliferation,
adhesion, migration and invasion in oral cancer
cells, Oral Oncology , 09 June 2008
8. MK Kang et al , 2007 , Elevated Bmi-1
expression is associated with dysplastic cell
transformation during oral carcinogenesis and
is required for cancer cell replication and
survival, British Journal of Cancer (2007) 96,
126 – 133
9. Chang-Hyun Kim et al , 2006, The RNA
Interference of Amino Acid Transporter
LAT1Inhibits the Growth of KB Human Oral
Cancer Cells, ANTICANCER RESEARCH 26:
2943-2948 (2006)
10. GowharShafi et al, 2008, RNAi as a novel
therapeutic platform technology for oncological
solutions, Biotechnology and Molecular Biology
Review Vol. 4 (3), pp. 055-070, June 2008
Vol. 14 No. 1
Jan-Apr 2018